NCT06366217View on ClinicalTrials.gov

Efficacy of the MydCombi on Pupillary Dilation in Pediatric and Adult Patients

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
DilationPupil Reaction Absent
Interventions
DEVICE

MydCombi Device

ophthalmic spray

DRUG

MydCombi Drug

Tropicamide 1% and phenylephrine HCl 2.5%

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT06366217 - Efficacy of the MydCombi on Pupillary Dilation in Pediatric and Adult Patients | Biotech Hunter | Biotech Hunter